Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
MAREK'S DISEASE LIVE VIRUS STRAIN CVI988; HERPES VIRUS OF TURKEYS (HVT) STRAIN FC 126
ZOETIS AUSTRALIA PTY LTD
MDV (HVT-FC 126)(1000PFU/Ds)+MDV (CVI 988)(1000PFU/Ds)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
MAREK'S DISEASE LIVE VIRUS STRAIN CVI988 VACCINE-VIRAL Active 1000.0 PFU/dose; HERPES VIRUS OF TURKEYS (HVT) STRAIN FC 126 VACCINE-VIRAL Active 1000.0 PFU/dose
#(amp=1000; #doses); 5x2mL Amps
VM - Veterinary Medicine
ZOETIS AUSTRALIA
EMBRYONATED CHICKEN EGG | POULTRY CHICKS | CHICKENS | DAY OLD CHICKS | HATCHLINGS
IMMUNOTHERAPY
MAREK'S DISEASE | VACCINE | EQUINE ROTAVIRUS | HERPES VIRUS OF TURKEYS (HVT)
Poison schedule: 0; Withholding period: WHP: NIL; Host/pest details: EMBRYONATED CHICKEN EGG: [MAREK'S DISEASE, VACCINE]; POULTRY CHICKS: [MAREK'S DISEASE, VACCINE]; For the subcutaneous vaccination of healthy one-day-old chicks or the in ovo vaccination of 18-19 day old embryonated chicken eggs to aid in the prevention of the signs and lesions of Marek's disease.
Registered
2023-07-01
APPENDIX2 Australian Government Australian Pesticides and Veterinary Medicines Authority TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPs) (Veterinary Products) Select appropriate: D New Product (include all applicable RLPs) OR )( Variation (highlight instructions that are being varied). Approval no. of label being varied 53259/0802 Signal heading: Product name: Active constituenVs: Statement of claims: Net contents: Directions for Use Heading: Restraints: Contra indications: Precautions: Side effects: Dosage & administration: FOR ANIMAL TREATMENT ONLY Dn" ...,v,m/T Vaccine (Serotypes 1 and 3, Live Marek's Disease Viruses) Each ampoule contains serotype 3 Marek's disease virus Herpes Virus of Turkeys [HVT] strain FC 126, .:: 1 ,000 pfu per dose and Chicken herpesvirus strain CVI 988, .:: 1000 pfu per dose. The vaccine virus has been purified and grown in tissue cultures derived from specific pathogen free (SPF) embryos. The vaccine contains gentamicin as a preservative. This product is recommended for the subcutaneous vaccination of healthy one- day-old chicks or the _in _ _ovo _ vaccination of 18 to 19 day-old embryonated chicken eggs to aid in the prevention of the signs and lesions of Marek's disease. Each cane contains 5 x 1,000 dose ampoules DIRECTIONS FOR USE USE ALL PRODUCT WITHIN 2 HOURS OF OPENING Use entire contents when first opened. Read directions on leaflet before using this product. NA NA NA NA ~ 1. 2. 3. 4. 5. ...... A,irl~ve0 for Subcu\.g .. ~~w..> Adm~ .. ·~·· g ...... : Vaccinate healthy one-day-old chicks only. Flocks in unhealthy condition, suffering from other diseases or parasitic conditions, may show severe reactions. Avoid early exposure of chicks to Marek's disease to allow for development of protection. Use Poulvac® Marek's Diluent (Poulvac® Sterile Diluent) only. Store the diluent at room temperature. Avoid freezing or excessive temperatures (over 40°C). Wear protective clothing when withdrawing the vaccine ampoules from a liquid nitrogen refrigerator. Protect hands with gloves, wea Read the complete document
Product Name: Poulvac® CVI-HVT Vaccine (Serotypes 1 and 3, Live Marek's Disease Viruses) Page: 1 of 5 This revision issued: November, 2012 SAFETY DATA SHEET Issued by: Pfizer Animal Health Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER Pfizer Animal Health Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: 1800 814 883 Fax: (02) 9850 3399 __________________________________________________________ PFIZER ANIMAL HEALTH AUSTRALIA PTY LTD ABN 94 156 476 425 CHEMICAL NATURE: Suspension of live viruses in water. TRADE NAME: POULVAC ® CVI-HVT VACCINE (SEROTYPES 1 AND 3, LIVE MAREK'S DISEASE VIRUSES) APVMA CODE: 53259 PRODUCT USE: V accine to aid in the prevention of signs and lesions of Marek’s disease in chickens OTHER NAME: Serotypes 1 and 3, Live Marek’s Disease Viruses CREATION DATE: JULY, 2012 THIS VERSION ISSUED: NOVEMBER, 2012 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S24/25. Avoid contact with skin and eyes. SUSMP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Pinkish coloured slightly cloudy liquid when thawed. ODOUR: No specific odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S NOTE: DIFFERENT HAZARD ASSESSMENT CRITERIA OF SWA AND TGA MAY RESULT IN SEEMING INCONSISTENCIES BETWEEN MSDS A Read the complete document